NFKB1 and breast carcinoma: Similarly, in breast cancer-bearing rats treated with BBR (50 mg/kg), the increased levels of lipid peroxide (malonaldehyde), pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α), enzymatic antioxidants (superoxide dismutase and catalase), non-enzymatic antioxidants (glutathione and vitamin C), and transcription factor NF-κB were significantly decreased by the administration of BBR.